Publications
- Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy2020 | Faculty of Medicine in Hradec Králové
- In silico library screening to find novel anticancer agent with chemosensitizing properties: focus on targeting ataxia telangiectasia and Rad3 related kinase2024 | Faculty of Medicine in Hradec Králové
- 7-Azaindole, 2,7-diazaindole, and 1H-pyrazole as core structures for novel anticancer agents with potential chemosensitizing properties2022 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Countermeasures in organophosphorus intoxication: pitfalls and prospects2022 | Publication without faculty affiliation
- Non-covalent acetylcholinesterase inhibitors: In vitro screening and molecular modeling for novel selective insecticides2022 | Publication without faculty affiliation
- Physicochemistry shapes bioactivity landscape of pan-ABC transporter modulators: Anchor point for innovative Alzheimer's disease therapeutics2022 | Publication without faculty affiliation
- Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-D-Aspartate receptors2021 | Faculty of Pharmacy in Hradec Králové, Faculty of Science, Central Library of Charles University
- Huprine Y-Tryptophan heterodimers with potential implication to Alzheimer's disease treatment2021 | Faculty of Pharmacy in Hradec Králové, First Faculty of Medicine
- Effects of Novel Tacrine Derivatives on Mitochondrial Energy Metabolism and Monoamine Oxidase Activity-In Vitro Study2021 | First Faculty of Medicine
- Clinical Candidates Targeting the ATR-CHK1-WEE1 Axis in Cancer2021 | Publication without faculty affiliation
Loading network view...